Early research (Phase 1)Ended earlyNCT02122146What this trial is testingPF-06664178 In Patients With Advanced Solid TumorsWho this might be right forNeoplasms Pfizer 31
Not applicableStudy completedNCT07105553What this trial is testingGlove Compression for Chemotherapy-Induced NeuropathyWho this might be right forChemotherapy-induced Peripheral Neuropathy (CIPN)Gynecologic CancersOvarian Cancer (OvCa)+1 more Ankara Etlik City Hospital 76
Testing effectiveness (Phase 2)Looking for participantsNCT07050771What this trial is testingComprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer SurgeryWho this might be right forHepatopancreaticobiliary (HPB) MalignancyOvarian Cancer (OvCa)Kidney Cancers+1 more The Methodist Hospital Research Institute 148
Testing effectiveness (Phase 2)Ended earlyNCT02107378What this trial is testingEfficacy of DCVAC/OvCa Plus Standard of Care in Relapsed Platinum Resistant Epithelial Ovarian CarcinomaWho this might be right forEpithelial Ovarian Carcinoma SOTIO a.s. 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07117877What this trial is testingEtoposide Capsules Combined With Bevacizumab and Iparomlimab and Tuvonralimab in the Treatment of Platinum Resistant or Platinum Refractory Ovarian CancerWho this might be right forPlatinum Resistant Ovarian CancerPlatinum Refractory Epithelial Ovarian CancerOvarian Cancer (OvCa) Fudan University 33
Not applicableLooking for participantsNCT06760923What this trial is testingUrinary Proteomic Assessment of Ovarian Malignancy and Disease ProgressionWho this might be right forOvarian Cancer (OvCa) Xiangya Hospital of Central South University 240
Testing effectiveness (Phase 2)Study completedNCT00129727What this trial is testingCarboplatin Taxol Avastin in Ovarian Cancer (OVCA)Who this might be right forOvarian Cancer Massachusetts General Hospital 62
Large-scale testing (Phase 3)Not Yet RecruitingNCT07286162What this trial is testingTrauma-Focused Managing Cancer And Living Meaningfully (CALM-TF) for Newly Diagnosed and Recurrent Ovarian CancerWho this might be right forOvarian Cancer (OvCa)Recurrent Ovarian Cancer University Health Network, Toronto 300
Testing effectiveness (Phase 2)Looking for participantsNCT06051695What this trial is testingEvaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 ExpressionWho this might be right forSolid Tumor, AdultColorectal CancerNSCLC+17 more A2 Biotherapeutics Inc. 474
Not applicableLooking for participantsNCT07100288What this trial is testingAnatomopathological Analysis of the Infundibulopelvic Ligament in Patients With Ovarian CancerWho this might be right forOvarian CancerOvarian Cancer (OvCa)Ovarian Adenocarcinoma Complejo Hospitalario Universitario Insular Materno Infantil 200
Testing effectiveness (Phase 2)Study completedNCT02107937What this trial is testingPhase II Study DCVAC/OvCa Added to First Line Carboplatin and Paclitaxel Newly Diagnosed Epithelial Ovarian CarcinomaWho this might be right forOvarian NeoplasmsOvarian Epithelial Cancer SOTIO a.s. 136
Early research (Phase 1)Study completedNCT02222922What this trial is testingPF-06647020 For Adult Patients With Advanced Solid TumorsWho this might be right forNeoplasms Pfizer 138
Testing effectiveness (Phase 2)Study completedNCT03657966What this trial is testingDCVAC/OvCa After Standard-of-care Chemotherapy in Women With Relapse of Platinum-sensitive Epithelial Ovarian CancerWho this might be right forOvarian Cancer Recurrent SOTIO a.s. 33
Not applicableStudy completedNCT07241091What this trial is testingSurgiPerito Trial: High-Purity Type-I Collagen for Peritoneal Reconstruction After Cytoreductive SurgeryWho this might be right forPeritoneal Surface MalignancyPostoperative AdhesionBowel Obstruction+3 more Adichunchanagiri Institute of Medical Sciences, B G Nagara 60
Not applicableLooking for participantsNCT07616310What this trial is testingRectosigmoid Lesion Excision vs. Resection: A Non-Inferiority Randomized Comparison in Advanced Ovarian CancerWho this might be right forOvarian Cancer (OvCa) Second Affiliated Hospital, Zhejiang University, School of Medicine 300
Large-scale testing (Phase 3)Looking for participantsNCT07546500What this trial is testingAzenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein ExpressionWho this might be right forOvarian Cancer K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc 420
Early research (Phase 1)Study completedNCT02573259What this trial is testingA Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid TumorsWho this might be right forPart 1MELANOMASCCHN+6 more Pfizer 147
Not applicableNot Yet RecruitingNCT07586449What this trial is testingA Prospective Observational Study of Senaparib in the Treatment of Epithelial Ovarian CancerWho this might be right forOvarian Cancer (OvCa) Zhejiang Cancer Hospital 500
Testing effectiveness (Phase 2)Study completedNCT02107950What this trial is testingPhase II Study DCVAC/OvCa Plus Carboplatin Gemcitabine Relapsed Platinum (Pt)-Sensitive Epithelial Ovarian CarcinomaWho this might be right forOvarian NeoplasmsOvarian Cancer (OvCa)Ovarian Epithelial Cancer SOTIO a.s. 71
Large-scale testing (Phase 3)WithdrawnNCT03905902What this trial is testingDCVAC/OvCa and Standard of Care (SoC) in Relapsed Ovarian, Fallopian Tube, and Primary Peritoneal CarcinomaWho this might be right forOvarian CancerFallopian Tube CancerPeritoneal Carcinoma SOTIO a.s.